Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma

NCT05008965 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Asthma

Interventions

DRUG: FB825
DRUG: Placebo

Sponsor

Oneness Biotech Co., Ltd.

Collaborators

[object Object]